Lipopolysaccharide (LPS), NEU1, and IL-1β act in a positive feedback loop as enhancers of inflammation in monocytes/macrophages and may therefore promote atherosclerosis and plaque instability (20). The gene discussed is NEU1; the disease is atherosclerosis.